Amantadine in Parkinson’s Disease: An Expert Opinion 1st/2022

Amantadine has been in use since 1966; however, its use in Parkinson’s disease initiated in 1968, when an old woman experienced a remarkable remission in her symptoms of rigidity, tremor, and akinesia. Since then, the drug has been utilized in the management of Parkinson’s disease. The book provides a comprehensive understanding on amantadine and its pharmacological and clinical efficacy

• Written by practicing key opinion leaders in neurology.
• Covers basic aspects of Parkinsonism with description of various symptoms, pathophysiology, and management approach.
• Describes in detail the role of amantadine in the management of parkinsonism highlighting its clinical and safety parameters.
• Illustrated and summarized with tables and figures to enhance reading experience